Xvivo Perfusion AB
XVIVO.ST
#5117
Rank
NZ$2.16 B
Marketcap
$68.87
Share price
-0.22%
Change (1 day)
70.34%
Change (1 year)
Categories

Earnings for Xvivo Perfusion AB (XVIVO.ST)

Earnings in 2024 (TTM): NZ$18.82 Million

According to Xvivo Perfusion AB's latest financial reports the company's current earnings are NZ$65.99 Million. In 2023 the company made an earning of NZ$15.98 Million, an increase over its 2022 earnings that were of NZ$3.9 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Xvivo Perfusion AB from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$18.82 M17.76%
2023 NZ$15.98 M309.49%
2022 NZ$3.9 M226.49%
2021 NZ$1.19 M-110.72%
2020 -NZ$11.16 Million-1221.07%
2019 NZ$0.99 M-70.61%
2018 NZ$3.38 M117.32%
2017 NZ$1.55 M146.09%
2016 NZ$0.63 M-61.52%
2015 NZ$1.64 M-3.88%
2014 NZ$1.71 M-39.59%
2013 NZ$2.83 M